Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells

Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor

(2013) Yan Yang et al.   CELLULAR SIGNALLING

L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression

(2013) Yao-Jen Liang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat

(2013) Hua Yang et al.   JOURNAL OF SURGICAL RESEARCH

The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential

(2013) Hiroki Fujita et al.   KIDNEY INTERNATIONAL

Dipeptidyl Peptidase IV Inhibition Activates CREB and Improves Islet Vascularization through VEGF-A/VEGFR-2 Signaling Pathway

(2013) Balaji Samikannu et al.   PLoS One

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

(2012) Ayako Ojima et al.   AMERICAN JOURNAL OF PATHOLOGY

Inhibition of the Expression of TGF-�1 and CTGF in Human Mesangial Cells byExendin-4, a Glucagon-like Peptide-1Receptor Agonist

(2012) Wenbin Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence

(2012) A. R. Meloni et al.   DIABETES OBESITY & METABOLISM

PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production

(2011) Mehdi Daoudi et al.   GASTROENTEROLOGY

Glucagon-like peptide–1 suppresses advanced glycation end product–induced monocyte chemoattractant protein–1 expression in mesangial cells by reducing advanced glycation end product receptor level

(2011) Yuji Ishibashi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels

(2011) Bo Jiao et al.   BioScience Trends

GLP-1 receptor plays a critical role in geniposide-induced expression of heme oxygenase-1 in PC12 cells

(2010) Fei Yin et al.   ACTA PHARMACOLOGICA SINICA

Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A

(2010) Hisko Oeseburg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15

(2010) A. Puddu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The RAGE Axis

(2010) Shi Fang Yan et al.   CIRCULATION RESEARCH

Advanced glycation end products-induced apoptosis attenuated by PPARδ activation and epigallocatechin gallate through NF-κB pathway in human embryonic kidney cells and human mesangial cells

(2010) Yao-Jen Liang et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Exenatide and renal failure

(2010) J. C. Ferrer-Garcia et al.   DIABETIC MEDICINE

Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts

(2010) Yao-Jen Liang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes

(2010) Sho-ichi Yamagishi   EXPERIMENTAL GERONTOLOGY

Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy

(2010) Sho-ichi Yamagishi et al.   Oxidative Medicine and Cellular Longevity

Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression

(2009) Yuji Ishibashi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells

(2009) Yao-Jen Liang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive ratsThis article is one of a selection of papers published in the special issue Bridging the Gap: Where Progress in Cardiovascular and Neurophysiologic Research Meet.

(2008) Soumya Saha et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY